Park S H, AuCoin T A, Silverman D M, Schatz R A
Toxicology Program, Northeastern University, Boston, Massachusetts 02115.
J Toxicol Environ Health. 1994 Dec;43(4):469-81. doi: 10.1080/15287399409531935.
The present study investigates the time-dependent effect of acute intraperitoneal o-xylene administration (1 g/kg) on rat hepatic and pulmonary mixed-function oxidase (MFO) content and activity and microsomal membrane structural parameters for up to 12 h postadministration. The purpose of this study was to determine whether o-xylene has similar effects on these parameters as those previously observed for the m and p isomers. o-xylene decreased total pulmonary cytochrome P-450 content and aryl hydrocarbon hydroxylase (AHH) activity at all time points examined with maximal inhibition occurring at 3 h postdose. The isozyme-specific MFO activity responsible for AHH activity was examined using benzyloxyresorufin O-dealkylation (BROD) as a measure of CYP2B1 activity and ethoxyresorufin O-dealkylation (EROD) as a measure of CYP1A1 activity. Reduced pulmonary activity for both EROD and BROD was noted for the 12-h postexposure period, in agreement with the decreases in total cytochrome P-450 content and AHH activity data. In contrast, increased hepatic cytochrome P-450 content was noted at 6 and 12 h with slightly increased EROD activity and markedly increased BROD activity. Conjugated diene (CD) formation, and index of membrane peroxidation, and phospholipid (PL) and cholesterol (CL) content of the microsomal membranes were also examined in lung and liver to assess membrane structural integrity. Pulmonary CD formation was increased only at the 12-h time point, while hepatic CD formation was increased from 3 to 12 h. An increase in pulmonary microsomal PL and CL content was noted as early as 1 h postdose. In liver, PL content was increased as early as 3 h, with no change in CL content. An increase in the PL/CL ratio, suggesting an increase in membrane fluidity, was observed in pulmonary microsomes 12 h after dosing, and in hepatic microsomes at 3, 6, and 12 h postdose. There was no correlation between solvent tissue levels and MFO or membrane changes. It seems unlikely that the lipid changes are causal in the observed o-xylene-induced MFO alterations, since they precede membrane lipid changes. Further, MFO activity decreases in lung and increases in liver, whereas lipid parameters increase in both organs. While these data may indicate an organ-selective difference in the relationship between membrane lipid changes and MFO activity, it is more likely that these lipid changes represent alternate toxicological effects of o-xylene. The results of this study indicate that the metabolism of other xenobiotics may be altered in o-xylene-exposed individuals in an organ-selective fashion.
本研究调查了急性腹腔注射邻二甲苯(1 g/kg)对大鼠肝脏和肺脏混合功能氧化酶(MFO)含量、活性以及微粒体膜结构参数在给药后长达12小时内的时间依赖性影响。本研究的目的是确定邻二甲苯对这些参数的影响是否与之前观察到的间二甲苯和对二甲苯异构体的影响相似。在所有检测时间点,邻二甲苯均降低了肺脏总细胞色素P-450含量和芳烃羟化酶(AHH)活性,最大抑制作用出现在给药后3小时。使用苄氧基试卤灵O-脱烷基化(BROD)作为CYP2B1活性的指标,乙氧基试卤灵O-脱烷基化(EROD)作为CYP1A1活性的指标,检测了负责AHH活性的同工酶特异性MFO活性。在暴露后12小时期间,观察到肺脏EROD和BROD活性均降低,这与总细胞色素P-450含量和AHH活性数据的降低一致。相比之下,在6小时和12小时时观察到肝脏细胞色素P-450含量增加,EROD活性略有增加,BROD活性显著增加。还检测了肺脏和肝脏微粒体膜的共轭二烯(CD)形成、膜过氧化指标以及磷脂(PL)和胆固醇(CL)含量,以评估膜结构完整性。肺脏CD形成仅在12小时时间点增加,而肝脏CD形成从3小时到12小时增加。给药后1小时就观察到肺脏微粒体PL和CL含量增加。在肝脏中,PL含量早在3小时就增加,CL含量无变化。给药后12小时在肺脏微粒体中以及给药后3小时、6小时和12小时在肝脏微粒体中观察到PL/CL比值增加,表明膜流动性增加。溶剂组织水平与MFO或膜变化之间没有相关性。脂质变化似乎不太可能是观察到的邻二甲苯诱导的MFO改变的原因,因为它们先于膜脂质变化出现。此外,肺脏中MFO活性降低,肝脏中MFO活性增加,而两个器官中的脂质参数均增加。虽然这些数据可能表明膜脂质变化与MFO活性之间的关系存在器官选择性差异,但更有可能的是这些脂质变化代表了邻二甲苯的其他毒理学效应。本研究结果表明,在接触邻二甲苯的个体中,其他外源性物质的代谢可能以器官选择性方式发生改变。